Daily brief
India has ordered a temporary ban on the messaging app Telegram over concerns it was used to leak exam papers, including the NEET medical entrance test. Telegram CEO Pavel Durov reacted to the ban, while a whistleblower involved in the CBSE exam leak criticized the National Testing Agency's handling of the situation.
India’s pharma billionaire eyes the crown of world’s top insulin supplier.
Indian biochar developers remain optimistic on CDR demand despite Microsoft's procurement pace.
A US legal battle over a TCS trade secret scandal ended with a $220 million blow.
A weaker rupee helped India’s exports log a six-month high, with US imports surging 54%.
by WorldBrief & Maksim Micheliov | AI-generated summary